The assessed variables were the distribution of the type of stroke classification, the detection of the presence of any imaging contraindication to the tPA administration for acute ischemic lesions, confidence in the presence of a hyperdense intracranial artery sign (HMCA), the Alberta Stroke Program Early CT Score (ASPECTS) [10], and the reading time. This evidence concerns the gene PLAT and stroke disorder.